Investing.com - Bausch Health (NYSE: BHC) reported third quarter EPS of $-0.23, $1.26 worse than the analyst estimate of $1.03. Revenue for the quarter came in at $2.51B versus the consensus estimate of $2.42B.
Guidance
Bausch Health sees FY 2024 revenue of $9.50B-$9.68B versus the analyst consensus of $9.49B.
Bausch Health's stock price closed at $8.17. It is up 45.12% in the last 3 months and up 19.79% in the last 12 months.
Bausch Health saw 3 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Bausch Health's stock price’s past reactions to earnings here.
According to InvestingPro, Bausch Health's Financial Health score is "good performance".
Check out Bausch Health's recent earnings performance, and Bausch Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar